Evaluation of a trastuzumab-containing treatment regimen for patients with unresectable advanced or recurrent gastric cancer.

Namikawa, Tsutomu; Munekage, Eri; Munekage, Masaya; Maeda, Hiromichi; Yatabe, Tomoaki; Kitagawa, Hiroyuki; Sakamoto, Kouichi; Obatake, Masayuki; Kobayashi, Michiya; Hanazaki, Kazuhiro

Namikawa, Tsutomu; Munekage, Eri; Munekage, Masaya; Maeda, Hiromichi; Yatabe, Tomoaki; Kitagawa, Hiroyuki; Sakamoto, Kouichi; Obatake, Masayuki; Kobayashi, Michiya; Hanazaki, Kazuhiro.

Afiliação

Namikawa T; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.
Munekage E; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.
Munekage M; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.
Maeda H; Cancer Treatment Center, Kochi Medical School Hospital, Kochi 783-8505, Japan.
Yatabe T; Department of Anesthesiology, Kochi Medical School, Kochi 783-8505, Japan.
Kitagawa H; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.
Sakamoto K; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.
Obatake M; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.
Kobayashi M; Cancer Treatment Center, Kochi Medical School Hospital, Kochi 783-8505, Japan; Department of Human Health and Medical Sciences, Kochi Medical School, Kochi 783-8505, Japan.
Hanazaki K; Department of Surgery, Kochi Medical School, Kochi 783-8505, Japan.

Mol Clin Oncol ; 5(1): 74-78, 2016 Jul.

Article em En | MEDLINE | ID: mdl-27330770

Palavras-chave

gastric cancer; human epidermal growth factor receptor 2; trastuzumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google